| Name | Canrenoic Acid Potassium Salt |
|---|---|
| Synonyms |
POTASSIUM CANRENOATE
canrenoic acid potassium 17-HYDROXY-3-OXOPREGNA-4,6-DIENE-21-CBOXYLIC ACID Canrenoic acid potassium salt competitive,inhibit,hypertension,diuretic,SC-14266,fibrosis,Mineralocorticoid Rector,Canrenoate potassium,SC14266,Inhibitor,Canrenoate,Aldadiene,cdiac,SC (17α)-17-Hydroxy-3-oxopregna-4,6-diene-21-cboxylic Acid PotassiuM Salt EINECS 218-554-9 PotassiuM 17-Hydroxy-3-oxo-17α-pregna-4,6-diene-21-cboxylate Potassium canrenoate (jp15) Soldactone MF 465 a Soldactone (tn) Canrenoic acid potassium salt powder Potassium canrenoate 17-Hydroxy-3-oxopregna-4,6-diene-21-cboxylic acid potassium salt Canrenoate potassium (usan) D01943 CanrenoicAcidPotassiumSal PotassiuM Aldadiene 17a-Pregna-4,6-diene-21-cboxylic acid, 17-hydroxy-3-oxo-, potassium salt (7CI) Soldactona Kanrenol 4,6-ANDROSTADIEN-17ALPHA-YL-PROPIONIC ACID-17BETA-OL-3-ONE POTASSIUM SALT Venactone PotassiuM 3-(3-oxo-17β-hydroxy-4,6-androstadien-17α-yl)propionate 17-Hydroxy-3-oxo-17a-pregna-4,6-diene-21-cboxylic acid potassium salt Canrenone, potassium salt Canrenoate MFCD05662375 canrenone potassium Pregna-4,6-diene-21-cboxylic acid, 17-hydroxy-3-oxo-, monopotassium salt, (17a)- (9CI) PotassiuM β-(3-Oxo-17β-hydroxyandrosta-4,6-dien-17α-yl) Propionate 17-Hydroxy-3-oxopregna-4,6-diene-21-cboxylic acid, Potassium canrenoate PotassiuM 3-(17β-Hydroxy-3-oxoandrosta-4,6-dien-17-yl)propionate Cabrenoic Acid Potassium Salt Soludactone SC 14266 17a-Pregna-4,6-diene-21-cboxylic acid, 17-hydroxy-3-oxo-, monopotassium salt (8CI) CANRENOIC ACID POTASSIUM SALT 17-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid,Potassium canrenoate Free acid potassium salt 17-HYDROXY-3-OXOPREGNA-4,6-DIENE-21-CBOXYLIC ACID POTASSIUM SALT Potassium kaneliate |
| Description | Canrenoate (Aldadiene) potassium, a prodrug that releases canrenone, is a potent, competitive mineralocorticoid receptor (aldosterone receptor) antagonist. Potassium canrenoate, as a diuretic, is used for the research of hypertension[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vivo | Potassium canrenoate has been shown to cause in rats a dose-dependent increase in myelogenous leukemia and statistically significant increases in malignant tumor of the liver, thyroid, brain and mammary gland[2][3]. Potassium canrenoate (20 mg/kg/day; drinking water) reduces isoprenaline-induced cardiac fibrosis in the rat[4]. |
| References |
| Molecular Formula | C22H29KO4 |
|---|---|
| Molecular Weight | 396.56200 |
| Exact Mass | 396.17000 |
| PSA | 77.43000 |
| LogP | 2.55550 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R22 |
| Safety Phrases | S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | TU3500000 |
| HS Code | 2916209090 |
| HS Code | 2916209090 |
|---|---|
| Summary | 2916209090 other cyclanic, cyclenic or cyclotherpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |